BioSpace News Archive

Epic Sciences, in partnership with Memorial Sloan Kettering (MSK), have demonstrated that a liquid biopsy blood test may be used in clinical trials to find patients who are likely to benefit from PSMA-targeted therapies, before treatment is initiated

Purchases may be made in open-market transactions, in block transactions on or off an exchange,

MedeAnalytics, a pioneer in healthcare analytics, today announced that the company is celebrating its 25th anniversary.

INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is pleased to provide an update on its progress towards European Union Good Manufacturing Practices (“EU-GMP”) certification.

84 percent of the patients it manages in Michigan have seen a primary care physician (PCP) in the last year, well above the national average of 51 percent

The funding consisted of $32.3 million in Series B equity and $10 million in venture debt.

Pathologists and toxicology laboratories on the front lines of opioid crisis.

Immunexpress, Inc., today announced the receipt of ‘Notices of Allowance’ from both the U.S. Patent and Trademark Office (USPTO) and the European Patent Office for the patent entitled “Biomarker identification” (U.S. Application No.

Equipped with knowledge and backed by rich industry experience, British Biologicals, an award-winning global nutraceutical company, has announced Bharath Reddy, Director of International Business Development and Operations, will lead the company’s expansion into the United States for an end-to-end solution for the nutritional supplement industry.

First Approved Oncology Treatment From Amgen Astellas Joint Venture